TECH
Bio-Techne Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+28/100
Last price
72.42
▼ 0.16 (0.22%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
72.42
Prev close
72.58
Day high
72.61
Day low
72.41
Volume
2.89M
Market cap
$11.36B
P/E (TTM)
62.44
52W range
43.20 – 72.69
Day trading desk
Gap from prior close
-0.23%
Prior close 72.58
VWAP
72.45
-0.05% from price
Relative volume
1.78×
Unusually busy
Session range
0.47%
72.41 – 72.75
Position in range
3%
Near session low
ATR (14D)
0.17
0.23% of price
Prior day high
72.61
PDH
Prior day low
72.38
PDL
Bid / ask spread
—
Quote not published
Session volume
5.57M
Avg 3.12M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.07%
-1.9%
1M
0.00%
-1.2%
3M
+2.07%
-2.4%
6M
+34.55%
+16.4%
YTD
+23.16%
+8.9%
1Y
+15.06%
-1.4%
3Y
+6.41%
-75.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TECH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+372.07K
Net buying
Buy transactions
20
378.71K shares
Sell transactions
1
6.64K shares
Net transactions
+21
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
541.02K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 28, 26 | HIGGINS JOHN L Director |
CONVERSION | 15.94K | $403.28K | Direct |
| Aug 14, 26 | HIPPEL JAMES Chief Financial Officer |
— | 9.78K | — | Direct |
| Aug 14, 26 | KELDERMAN KIM Chief Executive Officer |
— | 21.47K | — | Direct |
| Aug 14, 26 | GEIST WILLIAM Officer |
— | 6.42K | — | Direct |
| Aug 14, 26 | BOHNEN SHANE General Counsel |
— | 4.35K | — | Direct |
| Aug 14, 26 | HERR AMY E. Director |
— | 589 | — | Indirect |
| Aug 14, 26 | CROUSE STEVEN C. Officer |
— | 5.42K | — | Direct |
| Jul 29, 26 | HIPPEL JAMES Chief Financial Officer |
CONVERSION | 62.07K | $2.95M | Direct |
| Jul 28, 26 | KELDERMAN KIM Chief Executive Officer |
CONVERSION | 35.00K | $1.67M | Direct |
| Jul 23, 26 | BOHNEN SHANE General Counsel |
CONVERSION | 448 | $21.32K | Direct |
| Jun 2, 26 | CROUSE STEVEN C. Officer |
— | 600 | — | Direct |
| May 8, 26 | HERR AMY E. Director |
SELL | 6.64K | $320.39K | Indirect |
| May 8, 26 | HERR AMY E. Director |
CONVERSION | 6.64K | $315.87K | Indirect |
| May 5, 26 | HIPPEL JAMES Chief Financial Officer |
CONVERSION | 62.00K | $2.95M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAUMGARTNER ROBERT V |
Director | 46.50K | Stock Award(Grant) |
BOHNEN SHANE |
General Counsel | 10.36K | Conversion of Exercise of derivative security |
GEIST WILLIAM |
Officer | 24.94K | Conversion of Exercise of derivative security |
HIGGINS JOHN L |
Director | 77.25K | Conversion of Exercise of derivative security |
HIPPEL JAMES |
Chief Financial Officer | 170.18K | Conversion of Exercise of derivative security |
KEEGAN JOSEPH D |
Director | 15.41K | Stock Award(Grant) |
KELDERMAN KIM |
Chief Executive Officer | 82.76K | Conversion of Exercise of derivative security |
NUSSE ROELAND |
Director | 44.56K | Sale |
SETH ALPNA |
Director | 15.41K | Stock Award(Grant) |
VESSEY RUPERT J |
Director | 10.99K | Stock Award(Grant) |
Fundamentals
Market cap$11.36B
Enterprise value$11.38B
Revenue (TTM)$1.22B
Gross profit$804.88M
EBITDA$334.11M
Net income$181.84M
EPS (TTM)$1.16
Free cash flow$229.65M
Total cash$265.48M
Total debt$289.09M
Book value / share$13.51
Shares outstanding156.82M
Float156.15M
Short % of float4.24%
Dividend yield0.44%
Beta (5Y)1.30
Valuation & profitability ratios
Trailing P/E62.44
Forward P/E31.32
PEG ratio2.11
Price / sales—
Price / book5.36
EV / revenue9.37
EV / EBITDA34.07
Gross margin66.24%
Operating margin27.87%
Profit margin14.97%
Return on equity9.03%
Return on assets6.67%
Debt / equity13.71
Current ratio4.55
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.22B | $1.22B | $1.16B | $1.14B | -0.4% |
| Operating revenue | $1.22B | $1.22B | $1.16B | $1.14B | -0.4% |
| Cost of revenue | $415.97M | $429.36M | $389.33M | $366.89M | -3.1% |
| Gross profit | $799.07M | $790.27M | $769.73M | $769.82M | +1.1% |
| Research & development | $94.77M | $99.50M | $96.66M | $92.49M | -4.8% |
| Selling, general & admin | $406.67M | $415.10M | $393.32M | $352.44M | -2.0% |
| Total operating expense | $526.46M | $547.47M | $523.32M | $478.82M | -3.8% |
| Operating income | $272.61M | $242.80M | $246.40M | $291.00M | +12.3% |
| Net interest income | -$5.41M | -$4.62M | -$12.41M | -$7.80M | -17.0% |
| Pre-tax income | $240.68M | $98.46M | $185.69M | $338.66M | +144.4% |
| Tax provision | $58.82M | $25.06M | $17.58M | $53.22M | +134.7% |
| Net income | $181.86M | $73.40M | $168.10M | $285.26M | +147.8% |
| Net income to common | $181.84M | $73.36M | $168.07M | $285.19M | +147.9% |
| Basic EPS | 1.17 | 0.47 | 1.07 | 1.81 | +148.9% |
| Diluted EPS | 1.16 | 0.46 | 1.05 | 1.76 | +152.2% |
| EBIT | $250.31M | $106.97M | $201.43M | $349.87M | +134.0% |
| EBITDA | $347.67M | $216.88M | $313.14M | $457.11M | +60.3% |
| Basic shares | 155.96M | 157.52M | 157.71M | 157.18M | -1.0% |
| Diluted shares | 157.01M | 159.72M | 160.77M | 161.85M | -1.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $264.71M | $162.19M | $151.79M | $180.57M | — | +63.2% |
| Cash & short-term investments | $264.71M | $162.19M | $152.86M | $204.31M | — | +63.2% |
| Accounts receivable | $216.59M | $206.88M | $241.39M | $218.47M | — | +4.7% |
| Inventory | $195.74M | $189.45M | $179.73M | $171.64M | — | +3.3% |
| Total current assets | $744.40M | $608.30M | $617.42M | $621.48M | — | +22.4% |
| Property, plant & equipment | $299.17M | $319.12M | $342.44M | $324.53M | — | -6.3% |
| Goodwill & intangibles | $1.28B | $1.35B | $1.48B | $1.41B | — | -5.0% |
| Total assets | $2.59B | $2.56B | $2.70B | $2.64B | — | +1.1% |
| Total current liabilities | $163.70M | $175.85M | $159.38M | $128.51M | — | -6.9% |
| Current debt | — | — | — | — | $12.50M | — |
| Long-term debt | $200.00M | $346.00M | $319.00M | $350.00M | — | -42.2% |
| Total debt | $289.09M | $444.06M | $419.54M | $454.96M | — | -34.9% |
| Total liabilities | $478.50M | $639.06M | $635.02M | $672.18M | — | -25.1% |
| Retained earnings | $1.14B | $1.07B | $1.33B | $1.31B | — | +7.3% |
| Shareholder equity | $2.11B | $1.92B | $2.07B | $1.97B | — | +9.9% |
| Working capital | $580.70M | $432.45M | $458.04M | $492.97M | — | +34.3% |
| Net tangible assets | $829.40M | $572.27M | $589.11M | $559.13M | — | +44.9% |
| Shares issued | 156.10M | 154.97M | 158.22M | 157.64M | — | +0.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $181.86M | $73.40M | $168.10M | $285.44M | +147.8% |
| Depreciation & amortisation | $97.36M | $109.90M | $111.71M | $107.24M | -11.4% |
| Stock-based compensation | $41.37M | $40.83M | $38.04M | $39.23M | +1.3% |
| Change in working capital | -$41.30M | $11.54M | -$10.11M | -$90.58M | -457.9% |
| Operating cash flow | $292.07M | $287.56M | $298.98M | $254.39M | +1.6% |
| Capital expenditure | -$28.85M | -$31.01M | -$62.88M | -$38.24M | +7.0% |
| Investing cash flow | -$18.19M | -$35.18M | -$203.03M | -$265.65M | +48.3% |
| Share buybacks | -$41.67M | -$275.73M | -$80.04M | -$19.56M | +84.9% |
| Dividends paid | -$49.92M | -$50.39M | -$50.42M | -$50.28M | +0.9% |
| Financing cash flow | -$169.11M | -$253.91M | -$122.40M | $22.62M | +33.4% |
| Free cash flow | $263.22M | $256.55M | $236.10M | $216.15M | +2.6% |
| End cash position | $264.71M | $162.19M | $151.79M | $180.57M | +63.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $321.19M | $311.42M | $295.88M | $286.56M | $316.96M | +3.1% |
| Operating revenue | $321.19M | $311.42M | $295.88M | $286.56M | $316.96M | +3.1% |
| Cost of revenue | $109.80M | $103.13M | $104.60M | $98.44M | $118.15M | +6.5% |
| Gross profit | $211.39M | $208.29M | $191.28M | $188.11M | $198.81M | +1.5% |
| Research & development | $23.95M | $23.45M | $23.13M | $24.24M | $26.03M | +2.1% |
| Selling, general & admin | $67.42M | $109.34M | $113.69M | $116.21M | $23.22M | -38.3% |
| Total operating expense | $116.40M | $132.79M | $136.82M | $140.45M | $82.12M | -12.3% |
| Operating income | $95.00M | $75.50M | $54.46M | $47.66M | $116.69M | +25.8% |
| Net interest income | -$750.00K | -$1.42M | -$1.27M | -$1.96M | -$1.59M | +47.2% |
| Pre-tax income | $70.68M | $71.22M | $50.78M | $47.99M | -$22.86M | -0.8% |
| Tax provision | $16.06M | $20.18M | $12.78M | $9.81M | -$5.18M | -20.4% |
| Net income | $54.62M | $51.05M | $38.01M | $38.19M | -$17.68M | +7.0% |
| Net income to common | $54.64M | $51.04M | $38.00M | $38.18M | -$17.70M | +7.1% |
| Basic EPS | 0.35 | 0.33 | 0.24 | 0.25 | -0.11 | +6.1% |
| Diluted EPS | 0.35 | 0.32 | 0.24 | 0.24 | -0.11 | +9.4% |
| EBIT | $72.80M | $73.63M | $52.95M | $50.92M | -$20.68M | -1.1% |
| EBITDA | $96.94M | $97.80M | $77.66M | $75.27M | $6.43M | -0.9% |
| Basic shares | 156.09M | 156.33M | 155.84M | 155.46M | 154.91M | -0.2% |
| Diluted shares | 157.03M | 157.40M | 157.00M | 156.36M | 155.76M | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $264.71M | $209.82M | $172.88M | $144.96M | $162.19M | +26.2% |
| Cash & short-term investments | $264.71M | $209.82M | $172.88M | $144.96M | $162.19M | +26.2% |
| Accounts receivable | $216.59M | $214.56M | $184.61M | $183.90M | $206.88M | +0.9% |
| Inventory | $195.74M | $201.18M | $205.45M | $203.19M | $189.45M | -2.7% |
| Total current assets | $744.40M | $688.05M | $637.43M | $609.51M | $608.30M | +8.2% |
| Property, plant & equipment | $299.17M | $301.31M | $302.63M | $311.06M | $319.12M | -0.7% |
| Goodwill & intangibles | $1.28B | $1.30B | $1.32B | $1.33B | $1.35B | -1.4% |
| Total assets | $2.59B | $2.55B | $2.52B | $2.53B | $2.56B | +1.4% |
| Total current liabilities | $163.70M | $153.28M | $140.43M | $144.54M | $175.85M | +6.8% |
| Long-term debt | $200.00M | $200.00M | $260.00M | $300.00M | $346.00M | 0.0% |
| Total debt | $289.09M | $290.32M | $350.89M | $394.47M | $444.06M | -0.4% |
| Total liabilities | $478.50M | $465.30M | $511.71M | $560.33M | $639.06M | +2.8% |
| Retained earnings | $1.14B | $1.15B | $1.11B | $1.08B | $1.07B | -0.1% |
| Shareholder equity | $2.11B | $2.09B | $2.01B | $1.97B | $1.92B | +1.1% |
| Working capital | $580.70M | $534.77M | $497.01M | $464.96M | $432.45M | +8.6% |
| Net tangible assets | $829.40M | $788.43M | $695.44M | $636.79M | $572.27M | +5.2% |
| Shares issued | 156.10M | 156.52M | 155.88M | 155.75M | 154.97M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $54.62M | $51.05M | $38.01M | $38.19M | -$17.68M | +7.0% |
| Depreciation & amortisation | $24.14M | $24.17M | $24.71M | $24.34M | $27.11M | -0.1% |
| Stock-based compensation | $5.23M | $10.49M | $13.96M | $11.68M | $4.55M | -50.2% |
| Change in working capital | $3.81M | -$4.12M | $1.85M | -$42.85M | $21.57M | +192.6% |
| Operating cash flow | $95.42M | $86.66M | $82.41M | $27.59M | $98.20M | +10.1% |
| Capital expenditure | -$8.48M | -$9.09M | -$5.92M | -$5.36M | -$4.89M | +6.7% |
| Investing cash flow | -$7.06M | -$5.82M | -$5.92M | $605.00K | $406.00K | -21.3% |
| Share buybacks | -$41.65M | $0 | $0 | -$24.00K | -$100.06M | — |
| Dividends paid | -$12.48M | -$12.52M | -$12.47M | -$12.44M | -$12.39M | +0.3% |
| Financing cash flow | -$33.21M | -$42.72M | -$48.99M | -$44.20M | -$90.45M | +22.3% |
| Free cash flow | $86.94M | $77.58M | $76.49M | $22.22M | $93.31M | +12.1% |
| End cash position | $264.71M | $209.82M | $172.88M | $144.96M | $162.19M | +26.2% |
Options analytics
Put / call volume
0.86
Call-heavy session
Put / call open interest
2.60
Positioning, not flow
Max pain
60.00
-17.2% from spot
ATM implied vol
36.6%
Nearest strike to spot
Skew (10% OTM)
-60.9%
Calls bid over puts
Call volume
84
Contracts, this expiry
Put volume
72
Contracts, this expiry
Heaviest call OI
65.00
54 contracts
Heaviest put OI
35.00
263 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.52 | 0.52 | +0.1% |
| Mar 2026 | 0.53 | 0.53 | -0.8% |
| Dec 2025 | 0.43 | 0.46 | +5.8% |
| Sep 2025 | 0.42 | 0.42 | -0.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.45 | 7 | $292.20M | +2.0% |
| Next quarter | 0.48 | 6 | $307.78M | +4.0% |
| Current year | 2.02 | 11 | $1.27B | +4.4% |
| Next year | 2.31 | 9 | $1.40B | +10.0% |
Analyst targets & ownership
Mean target$70.50
High target$73.00
Low target$50.00
Implied upside-2.65%
Analyst count10
ConsensusHOLD
Strong buy / Buy0 / 1
Hold12
Sell / Strong sell0 / 0
Held by insiders0.34%
Held by institutions114.78%
Institutions holding815
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
72.49
-0.09% from price
SMA 20
72.40
+0.04% from price
SMA 50
72.31
+0.17% from price
SMA 100
66.22
+9.36% from price
SMA 200
62.19
+16.46% from price
EMA 12
72.45
-0.05% from price
EMA 26
72.32
+0.14% from price
EMA 50
71.21
+1.69% from price
RSI (14)
54.9
Neutral
MACD (12,26,9)
0.13
Hist -0.04
ATR (14)
0.17
0.23% of price
Realised vol 30D
2.1%
Annualised
Bollinger upper
72.68
20, 2σ
Bollinger lower
72.12
20, 2σ
50 / 200 cross
Golden
72.31 vs 62.19
Trend bias
Above 200
+16.46%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.79
Less volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
2.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-39.3%
Peak to trough
Max drawdown 5Y
-67.0%
Peak to trough
ATR 14
0.17
0.23% of price
Beta (reported)
1.30
5Y monthly, from filing
Short interest
Shares short
6.63M
Prior 6.46M
Change vs prior
+2.5%
Shorts adding
% of float
4.24%
Normal
% of shares out
4.23%
Against total outstanding
Days to cover
2.7
Liquid
Float
156.15M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Jul 9, 26 | RBC Capital | DOWNGRADE | Outperform | Sector Perform |
| Jun 30, 26 | TD Cowen | DOWNGRADE | Buy | Hold |
| Jun 30, 26 | Benchmark | DOWNGRADE | Buy | Hold |
| Jun 29, 26 | Citigroup | DOWNGRADE | Buy | Neutral |
| Jun 26, 26 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Jun 26, 26 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Jun 26, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jun 11, 26 | Piper Sandler | INITIATED | — | Neutral |
| May 7, 26 | Citigroup | MAINTAINED | Buy | Buy |
| May 7, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| May 7, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
Dividends & splits
Forward rate$0.32 / yr
Forward yield0.44%
5-year avg yield0.43%
Payout ratio27.59%
Ex-dividend dateAug 24, 2026
Next pay dateSep 4, 2026
Last split4:1
Split dateNov 30, 2022
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-23
Corporate Changes & Voting Matters
8-K · 2026-09-14
Proxy Statements
DEFA14A · 2026-09-09
Proxy Statements
DEFA14A · 2026-09-02
Proxy Statements
DEFA14A · 2026-08-25
Periodic Financial Reports
10-K · 2026-08-24
Proxy Statements
DEFM14A · 2026-08-20
Corporate Changes & Voting Matters
8-K · 2026-08-12
Headlines
INCY or TECH: Which Is the Better Value Stock Right Now?
Zacks · 7d ago
2 Cash-Producing Stocks Worth Investigating and 1 We Brush Off
StockStory · 9d ago
Bio-Techne (TECH) Shareholders Approve the Merck KGaA Takeover and Reject the Pay Package
Insider Monkey · 11d ago
Is Bio-Techne Stock Outperforming the Nasdaq?
Barchart · 13d ago
Bio-Techne Shareholders Approve Takeover by Merck KGaA
MT Newswires · 14d ago
3 Reasons to Sell TECH and 1 Stock to Buy Instead
StockStory · 14d ago
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
PR Newswire · 14d ago
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
CNW Group · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.